News
Altesa BioSciences today announced positive topline results from its Phase 2 placebo-controlled study examining the effects of vapendavir in COPD patients challenged with rhinovirus. In this study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback